India Business News

Sign Up to Connect With Companies

  • Send Your Proposal & Company Profile.
  • Enhanced Filtered Search options.
  • Access & Download Database of the Companies.
  • CRM Access - Create & manage the leads & you can track the status.
  • View companies key figures details such as turnover, no of employees etc.
  • Create Account Already have an Account ? Login
img
Boehringer Ingelheim GmbH

The CHMP of the EMA has issued a positive opinion for an update of the Summary of Product Characteristics (SmPC) for Pradaxa® (dabigatran etexilate); The CHMP recommends to include data showing that catheter ablation can be conducted in patients o

img
Tata Housing Pvt. Ltd.

Myst is the first project to be registered under RERA in Himachal Pradesh

img
Power2SME

Power2SME Announces Series E Financing investments from existing investors Inventus Capital Partners, Accel, Kalaari Capital and Nandan Nilekani with participation from IFC, a member of the World Bank Group

img
CA Technologies

New global research shows innovators who embrace the promise of Modern Software Development drive greater results with agile processes, attention to security

img

The 4th edition of BERG Real Estate Awards dwelt on the challenges in promoting access to affordable & Smart Housing in Emerging Markets and honored Developers, Project Consultants, Architects & Interior designers from across India

img
SES

The only private Turkish TV channel to broadcast in Africa relies on SES Video to maximize its reach

img
Crestron India

Global leader in automation control and advanced systems announced its dedicated, physical brand presence in India

img
ixigo.com

Kalagato study ranks ixigo as 2nd biggest mobile travel app in India

img
Prudent Corporate

Now, all first time Mutual Fund investors can complete their KYC - a one-time mandatory process, in just 2 mins

img
NIKE, Inc.

Using New NikeConnect Technology, Retail Jerseys Will Unlock Exclusive Experiences and Customized Content for Fans' Favorite Teams and Players

img
Boehringer Ingelheim

Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Cyltezo® (adalimumab biosimilar) for the treatment of multiple chronic inflammatory diseases; Recommendation based on e